Phase 1/2 study of KHK7580
Phase 1
- Conditions
- Secondary hyperparathyroidism in patients receiving hemodialysis
- Registration Number
- JPRN-jRCT2080222208
- Lead Sponsor
- Kyowa Hakko Kirin Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Written informed consent
- Stable chronic renal disease patients receiving hemodialysis 3 times weekly for at least 12 weeks prior to the screening
- intact PTH value of 240 pg/mL or more at the screening
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety<br><br>Number and types of adverse events, laboratory tests, vital signs, electrocardiogram and ophthalmologic examination
- Secondary Outcome Measures
Name Time Method